BDBM202589 US10035761, Compound 13d::US9238625, 13d

SMILES CCCCSCCCCNC(CC(C)C)C1(CCC1)c1ccc(Cl)c(Cl)c1

InChI Key InChIKey=FXJPORQCJXBCON-UHFFFAOYSA-N

Data  6 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 202589   

TargetSodium-dependent noradrenaline transporter(Human)
Revivia Pharmaceuticals

US Patent
LigandPNGBDBM202589(US10035761, Compound 13d | US9238625, 13d)
Affinity DataKi:  51nMAssay Description:The monoamine transporters inhibitory activities of selected cycloalkylmethylamines of Formula (I) are reported herein. The compounds were evaluated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Revivia Pharmaceuticals

US Patent
LigandPNGBDBM202589(US10035761, Compound 13d | US9238625, 13d)
Affinity DataKi:  51.0nMAssay Description:The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetSodium-dependent serotonin transporter(Human)
Revivia Pharmaceuticals

US Patent
LigandPNGBDBM202589(US10035761, Compound 13d | US9238625, 13d)
Affinity DataKi:  65.3nMAssay Description:The monoamine transporters inhibitory activities of selected cycloalkylmethylamines of Formula (I) are reported herein. The compounds were evaluated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetSodium-dependent serotonin transporter(Human)
Revivia Pharmaceuticals

US Patent
LigandPNGBDBM202589(US10035761, Compound 13d | US9238625, 13d)
Affinity DataKi:  65.3nMAssay Description:The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetSodium-dependent dopamine transporter(Human)
Revivia Pharmaceuticals

US Patent
LigandPNGBDBM202589(US10035761, Compound 13d | US9238625, 13d)
Affinity DataKi:  104nMAssay Description:The monoamine transporters inhibitory activities of selected cycloalkylmethylamines of Formula (I) are reported herein. The compounds were evaluated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetSodium-dependent dopamine transporter(Human)
Revivia Pharmaceuticals

US Patent
LigandPNGBDBM202589(US10035761, Compound 13d | US9238625, 13d)
Affinity DataKi:  104nMAssay Description:The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent